News 28.08.2024 Schlieren / Zurich, Switzerland, 27 August, 2024 – Memo Therapeutics AG (or “MTx”), a late-stage biotech company translating unique human immune responses into superior medicines to treat viral infections and cancer, today announces that Alex Bastian has joined the Company as VP Commercial Strategy. Alex Bastian is an experienced commercial leader in the biotech...
News 27.08.2024 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR: Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics ("Molecular Partners" or the "Company"), today announced corporate highlights and unaudited...
News 20.08.2024 August 19, 2024 - Zurich, Switzerland, Brussels, Belgium, and New York, US InSphero, a leading innovator in 3D Cell Culture and Organ-on-Chip technology, has announced a new collaboration with Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, and the Université Libre de Bruxelles (ULB) Center for Diabetes Research. With funding from...
Events, External events
Event date: 17.10.2024
Registrations are now open for the 7th Annual Open Innovation in Life Sciences conference (#OILS24), taking place on 17th October 2024. This year the conference's theme is ‘Artificial Intelligence in Health and Longevity’.
Register Now and become part of a day full of dynamic discussions on the role of AI in health and aging sciences,...
News 08.08.2024 Schlieren (Zurich), Switzerland, August 8, 2024 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced financial results for the first half of 2024. Revenue from direct MagnetOs product sales were CHF 31.6 million compared to CHF 12.2 million in H1 2023. Total revenue...